1-3 of 3
Eric Schafer
Close
Sort by
Journal Articles

Combining Atovaquone with Intensive Conventional Chemotherapy for Pediatric Acute Myeloid Leukemia (AML) Is Feasible and Well Tolerated

Alexandra McLean Stevens, Eric Schafer, Minhua Li, Maci Terrell, Raushan Rashid, Hana Paek, Allison Weisnicht, Noah J Keogh, Michelle C Alozie, Hailey H Oviedo, Alan K Gonzalez, Alicia Mangubat-Medina, Haopei Wang, Eunji Jo, Cara A Rabik, Claire Bocchini, Susan Hilsenbeck, Zachary T Ball, Todd M. Cooper, Michele Redell
Journal: Blood
Blood (2021) 138 (Supplement 1): 2312.
https://doi.org/10.1182/blood-2021-146057
Published: 2021
Journal Articles

Phase 1 Study of Decitabine and Vorinostat Followed By Fludarabine, Cytarabine and G-CSF (FLAG) in Children, Adolescents and Young Adults with Relapsed/Refractory AML: Report from the Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) Consortium

Lauren Pommert, MDMS, Deepa Bhojwani, MD, Richard Sposto, PhD, Ellynore Florendo, Eric Schafer, MD, Nathan Gossai, MD, Van Thu Huynh, MD, Sridhar Rao, MD PhD, Michael J. Burke, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1325.
https://doi.org/10.1182/blood-2019-127298
Published: 2019
Journal Articles

Promoter hypermethylation in MLL -r infant acute lymphoblastic leukemia: biology and therapeutic targeting

Eric Schafer, Rafael Irizarry, Sandeep Negi, Emily McIntyre, Donald Small, Maria E. Figueroa, Ari Melnick, Patrick Brown
Journal: Blood
Blood (2010) 115 (23): 4798–4809.
https://doi.org/10.1182/blood-2009-09-243634
Published: 2010
Includes: Supplemental data